Cardiovascular Risk Factors and Total Serum Antioxidant Capacity in Healthy Men and in Men with Coronary Heart Disease

Table 2

Correlation coefficients of total antioxidant capacity measures and uric acid concentration to age, selected anthropometric, biochemical, and blood pressure characteristics in men with and without CHD.

Variable	Group I (CHD patients)			Group II (without CHD)
	TAC-FRAS; (mmol FeCl2·L^−1)	TAC-DPPH; (% reduction)	UA; (mg·dL^−1)	TAC-FRAS; (mmol FeCl2·L^−1)	TAC-DPPH; (% reduction)	UA; (mg·dL^−1)
Age (years)	−0.09	−0.06	−0.08	0.08	0.006	0.01
Body mass (kg)		0.05			−0.06
BMI (kg·m^−2)		0.04			0.02
Waist circumference (cm)					−0.02
WHR					0.13
Percentage of body fat		−0.02		0.11	0.07
SBP (mmHg)		0.01	0.10	0.09	0.06	0.05
DBP (mmHg)		0.02		0.14	0.09	0.06
TC (mg·dL^−1)		−0.06	0.08	−0.01	−0.11	−0.07
LDL-C (mg·dL^−1)	0.04	−0.10	−0.07	−0.03	−0.11	−0.07
HDL-C (mg·dL^−1)	−0.05	−0.04	−0.04	−0.05	−0.09	−0.11
TC/HDL-C ratio	0.12	−0.03	0.05	0.03	0.02	0.04
TG (mg·dL^−1)		0.07		0.12	−0.01	0.13
Glucose (mg·dL^−1)	0.14		0.09	0.06	0.02	0.09
UA (mg·dL^−1)

, , .
BMI: body mass index; WHR: waist-to-hip ratio; SBP: systolic blood pressure; DBP: diastolic blood pressure; TC: total cholesterol; LDL-C: low density lipoprotein cholesterol; HDL-C: high density lipoprotein cholesterol; TG: triglycerides; UA: uric acid; TAC: total antioxidant capacity; FRAS: ferric reducing ability of serum; DPPH: 2.2-diphenyl-1-picryl-hydrazyl; CHD: coronary heart disease.